Katriina Vuolteenaho

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 12

Top Venues

International journal of molecular sciences

Mediators of inflammation

RMD open

PloS one

University of Tampere, Faculty of Medicine and Life Sciences, Pharmacology / Immunopharmacology Research Group

University of Tampere, Faculty of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Tampere, Faculty of Medicine and Life Sciences, Pharmacology / Immunopharmacology Research Group

Finland

Lecturer in pharmacology

Education History

University of Tampere, Faculty of Medicine Sep 14o 2005

Finland

PHD :: Pharmacology

Publications

Morena Scotece, Mari Hämäläinen, Tiina Leppänen, Katriina Vuolteenaho, Eeva Moilanen
MKP-1 Deficiency Exacerbates Skin Fibrosis in a Mouse Model of Scleroderma. International journal of molecular sciences 24 (5) (2023)
Leevi Halonen, Antti Pemmari, Elina Nummenmaa, Mari Hämäläinen, Teemu Moilanen, Katriina Vuolteenaho, Eeva Moilanen
Human Osteoarthritic Chondrocytes Express Nineteen Different TRP-Genes-TRPA1 and TRPM8 as Potential Drug Targets. International journal of molecular sciences 24 (12) (2023)
Morena Scotece, Mari Hämäläinen, Tiina Leppänen, Katriina Vuolteenaho, Eeva Moilanen
MKP-1 Deficiency Exacerbates Skin Fibrosis in a Mouse Model of Scleroderma. International journal of molecular sciences 24 (5) (2023)
Leevi Halonen, Antti Pemmari, Elina Nummenmaa, Mari Hämäläinen, Teemu Moilanen, Katriina Vuolteenaho, Eeva Moilanen
Human Osteoarthritic Chondrocytes Express Nineteen Different TRP-Genes-TRPA1 and TRPM8 as Potential Drug Targets. International journal of molecular sciences 24 (12) (2023)
Leevi Halonen, Antti Pemmari, Elina Nummenmaa, Mari Hämäläinen, Teemu Moilanen, Katriina Vuolteenaho, Eeva Moilanen
Human Osteoarthritic Chondrocytes Express Nineteen Different TRP-Genes-TRPA1 and TRPM8 as Potential Drug Targets. International journal of molecular sciences 24 (12) (2023)
Morena Scotece, Mari Hämäläinen, Tiina Leppänen, Katriina Vuolteenaho, Eeva Moilanen
MKP-1 Deficiency Exacerbates Skin Fibrosis in a Mouse Model of Scleroderma. International journal of molecular sciences 24 (5) (2023)
Antti Laurikka, Katriina Vuolteenaho, Vesa Toikkanen, Timo Rinne, Tiina Leppänen, Mari Hämäläinen, Matti Tarkka, Jari O Laurikka, Eeva Moilanen
Inflammatory Glycoprotein YKL-40 Is Elevated after Coronary Artery Bypass Surgery and Correlates with Leukocyte Chemotaxis and Myocardial Injury, a Pilot Study. Cells 11 (21) (2022)
Konsta Kivimäki, Tiina Leppänen, Mari Hämäläinen, Katriina Vuolteenaho, Eeva Moilanen
Pinosylvin Shifts Macrophage Polarization to Support Resolution of Inflammation. Molecules (Basel, Switzerland) 26 (9) (2021)
Morena Scotece, Anna Koskinen-Kolasa, Antti Pemmari, Tiina Leppänen, Mari Hämäläinen, Teemu Moilanen, Eeva Moilanen, Katriina Vuolteenaho
Novel adipokine associated with OA: retinol binding protein 4 (RBP4) is produced by cartilage and is correlated with MMPs in osteoarthritis patients. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 69 (4) (2020)
Tuija Väänänen, Katriina Vuolteenaho, Hannu Kautiainen, Riina Nieminen, Timo Möttönen, Pekka Hannonen, Markku Korpela, Markku J Kauppi, Kari Laiho, Oili Kaipiainen-Seppänen, Riitta Luosujärvi, Tea Uusitalo, Toini Uutela, Marjatta Leirisalo-Repo, Eeva Moilanen, null null
Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial. PloS one 12 (8) (2017)
Tuija Väänänen, Lauri Lehtimäki, Katriina Vuolteenaho, Mari Hämäläinen, Panu Oksa, Tuula Vierikko, Ritva Järvenpää, Jukka Uitti, Hannu Kankaanranta, Eeva Moilanen
Glycoprotein YKL-40 Levels in Plasma Are Associated with Fibrotic Changes on HRCT in Asbestos-Exposed Subjects. Mediators of inflammation 2017 (2017)
Elina Nummenmaa, Mari Hämäläinen, Lauri J Moilanen, Teemu Moilanen, Katriina Vuolteenaho, Eeva Moilanen
TRPA1 expression is downregulated by dexamethasone and aurothiomalate in human chondrocytes: TRPA1 as a novel factor and drug target in arthritis. RMD open 3 (2) (2017)
Sirpa Leivo-Korpela, Lauri Lehtimäki, Mari Hämälainen, Katriina Vuolteenaho, Lea Kööbi, Ritva Järvenpää, Hannu Kankaanranta, Seppo Saarelainen, Eeva Moilanen
Adipokines NUCB2/nesfatin-1 and visfatin as novel inflammatory factors in chronic obstructive pulmonary disease. Mediators of inflammation 2014 (2014)
Tuija Väänänen, Anna Koskinen, Erja-Leena Paukkeri, Mari Hämäläinen, Teemu Moilanen, Eeva Moilanen, Katriina Vuolteenaho
YKL-40 as a novel factor associated with inflammation and catabolic mechanisms in osteoarthritic joints. Mediators of inflammation 2014 (2014)

Katriina Vuolteenaho.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Katriina Vuolteenaho